Unternehmensportrait
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager.
Vorstand & Aufsichtsrat
| Vorstandsvorsitzender |
| Jim Hollingshead |
| Vorstand |
| Wayde McMillan, Eric Benjamin, Lauren Budden, Laetitia Cousin, Patrick Crannell, Mark Field, Deborah Gordon, John Kapples, Dr. Trang Ly, Dan Manea, Prem Singh |
| Aufsichtsrat |
| Luciana Borio, Wayne A. I. Frederick, Jim Hollingshead, Jessica Hopfield, Michael R. Minogue, Corinne Nevinny, Shacey Petrovic, Timothy J. Scannell, Elizabeth Weatherman |
Unternehmensinformationen
| Name: |
Insulet Corporation |
| Adresse: |
100 Nagog Park,Acton, MA 01720 |
| Telefon: |
(+1) 978-600-7000 |
| Fax: |
(+1) 978-600-0120 |
| E-Mail: |
-
|
| Internet: |
https://www.insulet.com/ |
| Industrie: |
Gesundheitswesen |
| Sektor: |
Medizintechnische Produkte |
| Sub-Sektor: |
- |
| Ende des Finanzjahres: |
31.12 |
| Streubesitz: |
- |
| IPO Datum: |
15.05.2007 |
Investor Relations
| Name: |
Deborah R. Gordon |
| IR Telefon: |
- |
| IR Fax: |
- |
| IR E-Mail: |
ir@insulet.com
|
